Topics

Glioblastoma | Treatment | Targeted therapy | Tyrosine kinase inhibitors

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Tyrosine kinase inhibitors

2026

Wei P, Jiang J, Xiao M, Zhang Y.
Efficacy and safety of tyrosine kinase inhibitor combination therapy for glioblastoma: a meta-analysis with trial sequential analysis of randomized controlled trials.
Front Oncol. 2026 Apr 20;16:1796708. doi: 10.3389/fonc.2026.1796708. PMID: 42088219. ˍ

Fu AZ, Mowforth OD, Chintapalli R, Brown S, Hardyman F, Mair R.
Receptor tyrosine kinase targeted therapies in glioblastoma: a systematic review.
Front Med (Lausanne). 2026 Sep 17;13:1928491. doi: 10.3389/fmed.2026.1928491. PMID: 42824982. ˍ